Viral related tools against SARS-CoV-2

Simple item page
UDC.coleccionInvestigaciónes_ES
UDC.departamentoFisioterapia, Medicina e Ciencias Biomédicases_ES
UDC.grupoInvInvestigación en Microbiología (INIBIC)es_ES
UDC.institutoCentroINIBIC - Instituto de Investigacións Biomédicas de A Coruñaes_ES
UDC.issue10es_ES
UDC.journalTitleViruseses_ES
UDC.startPage1172es_ES
UDC.volume12es_ES
dc.contributor.authorFernández-García, Laura
dc.contributor.authorPacios Santamaría, Olga
dc.contributor.authorGonzález-Bardanca, Mónica
dc.contributor.authorBlasco, Lucía
dc.contributor.authorBleriot Rial, Inés
dc.contributor.authorAmbroa, Antón
dc.contributor.authorLópez Díaz, María
dc.contributor.authorBou, Germán
dc.contributor.authorTomás, María
dc.date.accessioned2025-02-24T11:50:40Z
dc.date.available2025-02-24T11:50:40Z
dc.date.issued2020-10-16
dc.descriptionReviewes_ES
dc.description.abstract[Abstract] At the end of 2019, a new disease appeared and spread all over the world, the COVID-19, produced by the coronavirus SARS-CoV-2. As a consequence of this worldwide health crisis, the scientific community began to redirect their knowledge and resources to fight against it. Here we summarize the recent research on viruses employed as therapy and diagnostic of COVID-19: (i) viral-vector vaccines both in clinical trials and pre-clinical phases; (ii) the use of bacteriophages to find antibodies specific to this virus and some studies of how to use the bacteriophages themselves as a treatment against viral diseases; and finally, (iii) the use of CRISPR-Cas technology both to obtain a fast precise diagnose of the patient and also the possible use of this technology as a cure.es_ES
dc.description.sponsorshipThis study was funded by grants PI16/01163 and PI19/00878 awarded to M. Tomás within the State Plan for R+D+I 2013–2016 (National Plan for Scientific Research, Technological Development and Innovation 2008-2011) and co-financed by the ISCIII-Deputy General Directorate for Evaluation and Promotion of Research—European Regional Development Fund “A way of Making Europe” and Instituto de Salud Carlos III FEDER, Spanish Network for the Research in Infectious Diseases (REIPI, RD16/0016/0006) and by the Study Group on Mechanisms of Action and Resistance to Antimicrobials, GEMARA (SEIMC, http://www.seimc.org/).es_ES
dc.description.sponsorshipinfo:eu-repo/grantAgreement/MINECO/Programa Estatal de I+D+I Orientada a los Retos de la Sociedad/PI16%2F01163/ES/"Terapia FÁGICA CLÍNICA: Nuevos retos"es_ES
dc.description.sponsorshipinfo:eu-repo/grantAgreement/ISCIII/Programa Estatal de Generación de Conocimiento y Fortalecimiento del Sistema Español de I+D+I/PI19%2F00878/ES/"TRATAMIENTOS ANTI-TOLERANCIA Y/O ANTI-PERSISTENCIA BACTERIANA: CLAVES PARA LA LUCHA FRENTE A BACTERIAS RESISTENTES"es_ES
dc.description.sponsorshipinfo:eu-repo/grantAgreement/MINECO/Programa Estatal de I+D+I Orientada a los Retos de la Sociedad/RD16%2F0016%2F0006/ES/RED ESPAÑOLA DE INVESTIGACIÓN EN PATOLOGÍAS INFECCIOSASes_ES
dc.identifier.citationFernandez-Garcia L, Pacios O, González-Bardanca M, Blasco L, Bleriot I, Ambroa A, López M, Bou G, Tomás M. Viral related tools against SARS-CoV-2. Viruses. 2020 Oct 16;12(10):1172.es_ES
dc.identifier.doi10.3390/v12101172
dc.identifier.issn1999-4915
dc.identifier.urihttp://hdl.handle.net/2183/41248
dc.language.isoenges_ES
dc.publisherMDPIes_ES
dc.relation.urihttps://doi.org/10.3390/v12101172es_ES
dc.rightsCreative Commons Attribution 4.0 International License (CC-BY 4.0)es_ES
dc.rights.accessRightsopen accesses_ES
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es/*
dc.subjectCOVID-19es_ES
dc.subjectCRISPRes_ES
dc.subjectSARS-CoV-2es_ES
dc.subjectDiagnosises_ES
dc.subjectPhageses_ES
dc.subjectPreventiones_ES
dc.subjectTreatmentes_ES
dc.subjectViruseses_ES
dc.titleViral related tools against SARS-CoV-2es_ES
dc.typejournal articlees_ES
dspace.entity.typePublication
relation.isAuthorOfPublication909e08d1-6ed1-4b99-9e9e-c64eb72e7dea
relation.isAuthorOfPublication.latestForDiscovery909e08d1-6ed1-4b99-9e9e-c64eb72e7dea

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
FGarcia_Viral_2020.pdf
Size:
792.92 KB
Format:
Adobe Portable Document Format
Description:
Download

Collections

Investigación (FFISIO)